TITLE:
Alternate Day Buprenorphine Administration, Phase X - 15

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Buprenorphine

SUMMARY:

      The purpose of this study is to determine how subjects will make changes in the amount of
      medication received when given a monetary alternative to buprenorphine.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 34 Years to 51 Years
Criteria:

        Please contact site for information.
      
